Patents by Inventor Jeffrey Neal PACKMAN

Jeffrey Neal PACKMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating heterotopic ossification
    Patent number: 12138245
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Grant
    Filed: April 17, 2024
    Date of Patent: November 12, 2024
    Assignee: Clementia Pharmaceuticals Inc.
    Inventors: Clarissa Desjardins, Donna Roy Grogan, Jeffrey Neal Packman, Mark Harnett
  • METHODS FOR TREATING HETEROTOPIC OSSIFICATION
    Publication number: 20240350457
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Application
    Filed: June 28, 2024
    Publication date: October 24, 2024
    Inventors: Clarissa DESJARDINS, Donna Roy Grogan, Jeffrey Neal Packman, Mark Harnett
  • METHODS FOR TREATING HETEROTOPIC OSSIFICATION
    Publication number: 20240277667
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Application
    Filed: April 17, 2024
    Publication date: August 22, 2024
    Inventors: Clarissa DESJARDINS, Donna Roy GROGAN, Jeffrey Neal PACKMAN, Mark HARNETT
  • METHODS FOR TREATING HETEROTOPIC OSSIFICATION
    Publication number: 20230285360
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Application
    Filed: March 13, 2023
    Publication date: September 14, 2023
    Inventors: Clarissa DESJARDINS, Donna Roy GROGAN, Jeffrey Neal PACKMAN, Mark HARNETT
  • Methods for treating heterotopic ossification
    Patent number: 11622959
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: April 11, 2023
    Assignee: Clementia Pharmaceuticals Inc.
    Inventors: Clarissa Desjardins, Donna Roy Grogan, Jeffrey Neal Packman, Mark Harnett
  • METHODS FOR TREATING HETEROTOPIC OSSIFICATION
    Publication number: 20220054487
    Abstract: The invention describes dosing regimens for treating subjects with fibrodysplasia ossificans progressiva characterized by a quiescent period and a non-quiescent period, wherein a therapeutically effective amount of palovarotene is administered to the subjects during the non-quiescent period, little or no palovarotene is administered to the subjects during the quiescent period, and imatinib is administered to the subjects during the quiescent period and optionally during the non-quiescent period. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Application
    Filed: December 13, 2019
    Publication date: February 24, 2022
    Inventors: Clarissa DESJARDINS, Donna Roy GROGAN, Jeffrey Neal PACKMAN, Mark HARNETT
  • METHODS FOR TREATING HETEROTOPIC OSSIFICATION
    Publication number: 20210069152
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 11, 2021
    Inventors: Clarissa Desjardins, Donna Roy Grogan, Jeffrey Neal Packman, Mark Harnett
  • Methods for treating heterotopic ossification
    Patent number: 10864194
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: December 15, 2020
    Assignee: Clementia Pharmaceuticals Inc.
    Inventors: Clarissa Desjardins, Donna Roy Grogan, Jeffrey Neal Packman, Mark Harnett
  • METHODS FOR TREATING HETEROTOPIC OSSIFICATION
    Publication number: 20190216781
    Abstract: The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
    Type: Application
    Filed: June 8, 2017
    Publication date: July 18, 2019
    Inventors: Clarissa DESJARDINS, Donna Roy GROGAN, Jeffrey Neal PACKMAN, Mark HARNETT